PT Kalbe Farma Tbk. (IDX:KLBF)
Indonesia · Delayed Price · Currency is IDR 730.00
+15.00 (2.10%)
Oct 30, 2026, 4:13 PM WIB
PT Kalbe Farma Tbk. Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 38,310,263 | 35,324,544 | 32,627,776 | 30,449,134 | 28,933,503 | 26,261,195 |
Revenue Growth | 11.44% | 8.27% | 7.16% | 5.24% | 10.18% | 13.62% |
Gross Profit Gross Profit Growth | 14,343,301 | 13,793,357 | 12,723,136 | 11,551,489 | 11,518,601 | 11,105,061 |
Operating Income Operating Income Growth | 4,783,715 | 4,578,884 | 4,101,346 | 3,649,483 | 4,248,219 | 4,030,862 |
Net Income Net Income Growth | 3,770,548 | 3,664,998 | 3,240,637 | 2,766,748 | 3,382,210 | 3,183,621 |
Earnings Per Share EPS Growth | 83.22 | 80.51 | 70.16 | 59.81 | 72.71 | 67.92 |
EPS Growth | 8.60% | 14.74% | 17.30% | -17.74% | 7.05% | 16.48% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Distribution and Logistic Distribution and Logistic Growth | 13,725,568 | 12,210,729 | 10,900,590 | 9,806,880 | 10,801,381 | 9,752,472 |
Prescription Pharmaceutical Prescription Pharmaceutical Growth | 10,600,385 | 10,241,006 | 9,225,636 | 8,221,538 | 6,148,609 | 5,719,423 |
Nutritionals Nutritionals Growth | 8,306,279 | 8,046,292 | 8,188,189 | 8,371,560 | 7,830,659 | 7,166,475 |
Consumer Health Consumer Health Growth | 5,091,825 | 4,826,517 | 4,313,361 | 4,049,156 | 4,152,854 | 3,622,825 |
Total Total Growth | 37,724,057 | 35,324,544 | 32,627,776 | 30,449,134 | 28,933,503 | 26,261,195 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,423,231 | 4,485,583 | 4,866,432 | 3,397,917 | 4,095,076 | 6,475,171 |
Total Debt Total Debt Growth | 295,099 | 298,842 | 561,587 | 621,627 | 1,167,718 | 626,155 |
Net Cash (Debt) Net Cash Growth | 5,128,132 | 4,186,741 | 4,304,845 | 2,776,290 | 2,927,358 | 5,849,016 |
Net Cash Growth | 39.39% | -2.74% | 55.06% | -5.16% | -49.95% | 38.00% |
Net Cash Per Share Net Cash Per Share Growth | 113.19 | 91.97 | 93.20 | 60.02 | 62.93 | 124.78 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3,727,545 | 3,270,655 | 4,785,179 | 2,908,096 | 1,271,889 | 2,825,946 |
Capital Expenditures CapEx Growth | -823,624 | -725,801 | -907,909 | -881,551 | -705,458 | -503,910 |
Free Cash Flow Free Cash Flow Growth | 2,903,921 | 2,544,854 | 3,877,270 | 2,026,545 | 566,431 | 2,322,036 |
Free Cash Flow Growth | 7.80% | -34.37% | 91.32% | 257.77% | -75.61% | -29.52% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.44% | 39.05% | 39.00% | 37.94% | 39.81% | 42.29% |
Operating Margin | 12.49% | 12.96% | 12.57% | 11.99% | 14.68% | 15.35% |
Pretax Margin | 12.91% | 13.62% | 13.03% | 11.92% | 15.49% | 15.89% |
Profit Margin | 9.84% | 10.38% | 9.93% | 9.09% | 11.69% | 12.12% |
FCF Margin | 7.58% | 7.20% | 11.88% | 6.66% | 1.96% | 8.84% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 20.000 | 20.000 | 36.000 | 31.000 | 38.000 | 35.000 |
Dividend Per Share Growth | -44.44% | -44.44% | 16.13% | -18.42% | 8.57% | 25.00% |
Dividend Yield | 2.74% | 1.66% | 2.64% | 1.93% | 1.82% | 2.17% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.77 | 14.90 | 19.37 | 26.92 | 28.58 | 23.78 |
Forward PE | 8.41 | 14.58 | 18.65 | 19.72 | 25.34 | 22.83 |
P/FCF Ratio | 11.37 | 21.46 | 16.19 | 36.75 | 170.67 | 32.60 |
PS Ratio | 0.86 | 1.55 | 1.92 | 2.45 | 3.34 | 2.88 |